Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Freegold Intersects 3.62 g/t Au over 42m and 1.23 g/t Au over 170.7m (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Nuvo Pharmaceuticals Inc MRVFF

Healthcare Drug Manufacturers - Specialty & Generic
Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets. see more

OTCQX:MRVFF - Post Discussion

Nuvo Pharmaceuticals Inc > Prospectus
View:
Post by Marathon11 on Jun 08, 2021 3:15pm

Prospectus

We are approaching 90 days since the prospectus was filed.
In my opinion, it sure looks like the price has been manipulated over those 3 months.
Sure hope they aren't going to dilute us at this price level.
Will see.
Comment by UglyKidStock on Jun 09, 2021 11:50am
2021-05-28 Dobranowski, Anthony Edward 6,000 Buy in the public market at $1.45 per share $8,700.00 62,181 2021-05-26 Dobranowski, Anthony Edward 1,181 Buy in the public market at $1.50 per share $1,771.50 56,181 2021-05-20 Chicoine, Daniel 7,680  ...more  
Comment by UglyKidStock on Jun 25, 2021 1:00pm
More insider buying in June.   Price going up  approaching August 15 second quarter release
Comment by lscfa on Jul 08, 2021 8:39pm
I've seen 2 yr shelf prospectuses expire unused. They are for contingency planning.   
Comment by Marathon11 on Jul 20, 2021 4:53pm
I hope you are right and my guess was wrong.... however, it was April 21 (approx. 90 days ago) that they filed the final base shelf prospectus. Just coincidence? Today's trading didn't exactly look normal. As always, we will see.
Nuvo Pharmaceuticals Inc